Today’s stock pick update – Open Now

[Learn More]( Now Available – 2020 Spring Crop Outlook With the USDA Prospective Plantings report out, we have our first look at producer planting intentions for 2020. What does this mean for the crops and supply? How will the coronavirus pandemic affect demand and prices? Find all this and more!(Ad) [Get your answers in the 2020 Spring Crop Outlook here.]( LabCorp Shares Are Rising As Company Says It’s Expanding Availability For Its COVID-19 Antibody Test Oil rebounded with West Texas Intermediate crude up nearly 30% to $15.15 per barrel at the time of writing. The price collapse in oil over the last few weeks risks pushing the U.S. shale industry into complete shutdown, and operators are already switching off wells, retiring one in three drill rigs, abandoning fracking, laying off as many as 51,000 workers and reducing salaries, and some have even gone bankrupt in just weeks. While prices have recovered today after this week... [Read More]( Novavax Inc (NASDAQ: [NVAX]( Novavax shares are up nearly 20% over the last week after the biotech announced that it will be starting Phase 1 testing for its COVID-19 vaccine, NVS-CoV2373, in Australia in the coming weeks. “The urgent global race to develop a vaccine against the COVID-19 pandemic drove our rapid identification and selection of an optimal, highly immunogenic vaccin... [Read More]( BAX is an example of market risk from near-term pandemic effects One of the interesting phenomenons that I’ve observed in the last week or so is subtextual as it relates to the healthcare industry. While healthcare professionals are doing heroic work in treating the infected, massive amounts of work is being done to research, develop and test treatments and vaccines, and companies on the supply side are doing everything they can to provide the necessary support to keep all of those efforts going, it has also forced drastic measures related to elective pr... [Read More]( Featured Stock [NanoViricides, Inc. (NNVC) – Buy Price – $7.30 or better]( NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. [Read More]( Other Top Stories - [Preparation, quick action aid Germany, SKorea virus fight]( - [Closing prices for crude oil, gold and other commodities]( - [Hotels become barracks for health workers 'going to war']( - [Administration offers plan to cover COVID care for uninsured]( - [PG&E's top exec to end short stint at beleaguered utility]( Trend Following Picks - [NanoViricides, Inc. (NNVC) – Buy Price – $7.30 or better]( - [Inovio Pharmaceuticals, Inc. (INO) – Buy Price – $10.00 or better]( - [Tsakos Energy Navigation Limited (TNP) – Buy Price – $3.50 or better]( - [Pan American Silver Corp. (PAAS) – Buy Price – $20.00 or better]( - [Proteostasis Therapeutics, Inc. (PTI) – Buy Price – $1.65 or better]( [All Picks]( Reversal Picks - [Meritage Homes Corporation (MTH) Buy Target $44.78 Sell Target $56.84]( - [M.D.C. Holdings, Inc. (MDC) Buy Target $28.45 Sell Target $36.29]( - [JinkoSolar Holding Co., Ltd. (JKS) Buy Target $18.07 Sell Target $22.19]( - [Altair Engineering Inc. (ALTR) Buy Target $29.42 Sell Target $33.36]( - [the Rubicon Project, Inc. (RUBI) Buy Target $7.54 Sell Target $9.66]( [All Picks]( Already subscribed to our premium service? [Click here to Login.]( Not a TradersPro subscriber yet? [Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits]( --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019